Lermed is developing several approaches to improve diagnosis, prognosis and overall care for patients with neurodegenerative diseases. It leverages proprietary platforms to identify drug responders and turn clinical trial failures into success. This groundbreaking approach has the potential to unlock personalised medicine in the field of neurodegeneration and dementia.
| Website | http://lermed.ch |
| Employees | 3 (2 on RocketReach) |
| Industry | Biotechnology Research |
| Keywords | Patient Care, Neurodegenerative Diseases, Disease Diagnosis, Disease Modeling, Platform Technology, In-Vitro Diagnostics, Drug Discovery, Biotechnology, Precision Medicine, Therapeutic Development, Diagnostic Tools, Clinical Trials, Health Tech, Medical Research, Life Sciences, Data Analytics |
Looking for a particular Lermed employee's phone or email?
Elettra Santori is the Co-Founder and CEO of Lermed.
2 people are employed at Lermed.
Lermed is based in Lausanne, Vaud.